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1. Introduction 
Ethidium bromide (EB) has been reported to inter- 
fere with the DNA-dependent DNA-polymerase 
catalyzed synthesis of DNA in vitro [ 11. Since 
ethidium forms well-defined complexes with DNA 
the inhibition of the polymerase action may very well 
be the result of interaction between ethidium and 
template rather than a direct effect on the enzyme. 
In order to test this possibility, we undertook to study 
the inhibitory effect of this compound on the 
synthesis of DNA. We have also compared the results 
obtained to the corresponding data gathered using a 
structural analog of ethidium namely the 3,8-diamino- 
6-ethyl-S-methylphenanthridinium bromide (DEMB). 
2. Materials and methods 
Calf thymus DNA and deoxyribonucleotide tri- 
phosphates were obtained from Worthington 
Biochemical Corp., and [3H]TTP (specific activity 
54 Ci/mole) from Schwarz/Mann. DNA-polymerase I 
(EC 2.7.7.7.; 12.5 units/mg protein) and pancreatic 
DNase I (EC 3.1.4.5, 2000 units/mg protein) were 
purchased from Sigma Chemical Co. Ethidium 
bromide was obtained from Calbiochem. A crystalline 
sample of DEMB was kindly donated by Dr T. I. 
Watkins. 
Binding of the drugs to DNA was determined as 
described previously [ 21. Sample temperature was 
maintained at 37”Cby means of a 10 cm jacketed 
cell and a constant temperature circulator. 
The polymerase assay was essentially that of 
Bollum [3]. The reaction mixture (0.3 ml) contained: 
0.4 M potassium phosphate, pH 7.0; 8 mM MgClz ; 
0.33 mg/ml BSA; 1 mM 2-mercaptoethanol; 0.1 mM 
each of dATP, dGTP, dCTP; 0.1 mM of [3 H]TTP 
(15 000 cpm/nmole); 0.072 mg/ml activated calf 
thymus DNA; 8 pg/ml enzyme and the indicated 
amounts of inhibitor. The acid-insoluble radioactivity 
after 30 min of incubation at 37°C was measured in 
a toluene-based solution. 
Activation of the DNA template was carried out as 
described by Harwood et al. [4]. The method consists 
of partial digestion of the template with pancreatic 
DNase I (3.1 pg enzyme/mg DNA) for 10 min at 
37°C. 
3. Results 
The inhibiting effects of EB and DEMB on DNA 
polymerase are shown in fig. la. In both instances 
significant inhibition of the enzyme is noted which 
increases with increasing concentrations of the drug. 
Specifically EB at an added EB to DNA-phosphate 
ratio of 0.20 produced an 83% inhibition of the 
polymerase. The same ratio of added DEMB to phos- 
phate produced a 72% inhibition of the enzyme. 
Although these data do not provide any informa- 
tion as to whether the drug interferes with the 
priming activity of DNA or whether it affects the 
enzyme directly, a distinction between these two 
possibilities can be made by examining the activity 
of the enzyme as a function of template concentration 
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Fig. 1. - a) Inhibition of DNA-polymerase by EB (0) and 
DMEB (0) as a function of the added drug to DNA- 
phosphate ratio. - b) Inhibition of DNA polymerase by EB 
(0) and DMEB (0) as a function of the DNA-bound drug 
to DNA-phosphate ratio, r. 
Fig. 2. Effect of the variation in the concentration of DNA 
template on the inhibition of TTP incorporation into newly 
synthesized DNA by EB. (0) control; (0), 4.3 X 10s6 M 
EB. 
both in the presence and the absence of inhibitor. 
The Lineweaver-Burk plot (fig. 2) suggests hat 
the inhibition of the enzyme is related to the amount 
of template present in a competitive manner. Thus, 
it appears that the inhibitor has no effect on the 
enzyme itself but rather it interferes with the 
template activity of DNA. A similar conclusion has 
been reached previously concerning the inhibiting 
effect of EB on the DNA-dependent RNA polymerase- 
catalyzed synthesis of RNA [5]. 
A comparison between the inhibitory effects of 
EB and DEMB on DNA polymerase should, therefore, 
be made on the basis of the amounts of DNA-bound 
inhibitor rather than the total amount of added drug. 
It turns out that, although the binding properties of 
EB and DEMB are comparable, EB interacts ome- 
what more strongly with DNA. Specifically EB is 
characterized by an intrinsic association constant K
of1.6X lO’M_’ andDEMBbyaKof 1.0X 10’ M-’ 
as determined from the corresponding Scatchard 
plots. Both values are obtained from measurements in 
0.04 M potassium phosphate, 8 mM MgC12 buffer, 
pH 7; at 37°C i.e. under conditions imilar to those 
used in the assay for enzymic activity. 
These data permit the results to be presented as 
percent inhibition vs. amount of bound inhibitor 
(fig. lb). The obtained plot shows that the rate of 
DNA synthesis i  decreased almost in proportion to 
the amount of bound inhibitor. It is also apparent 
that EB is a somewhat more effective inhibitor of 
DNA-polymerase than DEMB, although when the 
data are expressed in terms of bound rather than 
added drug the difference in the inhibiting effect- 
iveness between EB and DEMB is decreased. 
4. Discussion 
Examination of the data shown in fig. lb suggests 
that the DNA polymerase activity is almost otally 
abolished at a ratio of bound ethidium to DNA phos- 
phate of about 0.18. The preferential stabilization 
of the double stranded conformation of DNA over 
the single stranded form of the polynucleotide, 
brought about by interaction with ethidium [6] is 
undoubtedly partly responsible for the inhibitory 
effect of the dye on the function of DNA-polymerase. 
A dissociation of the helix is required for replication 
and ethidium could interfere with this step. 
Alternatively the inhibition may result from the 
presence of bound ethidium molecules which restrict 
the length of DNA regions acting as templates to 
nucleotide sequences limited by neighboring drug 
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Fig. 3. The structures of ethidium bromide (EB), 3,8- 
diamino&ethyl-S-methylphenanthridinium bromide (DEMB) 
and 3,8diamino-5,6dimethylphenanthridinium bromide 
(DDMB). 
molecules. Ethidium is known to ‘intercalate’ i.e. 
become inserted between neighboring nucleotide 
bases in the double helix [7] and it appears that 
DEMB not only also intercalates but it may assume 
a conformation very similar to that of bound ethidium 
as well. This, at least is quite-likely in the case of 
3,8-diamino-5,6-dimethylphen-anthridinium bromide 
(DDMB) which is structurally very similar to DEMB 
(fig. 3) and which forms complexes with DNA with 
circular dichroism properties identical to those of the 
DNA-EB complex [2]. Therefore, as the ratio of 
bound drug increases, the length of the regions avail- 
able for replication may be decreased and a limit be 
reached at which these regions become too short to 
serve as effecti e templates. 
The mecha 
i 
sm of inhibition, which is based on 
the notion that he intercalated drug molecule serves 
as a barrier in th attachment or the movement of 
the enzyme along the polynucleotide template, was 
previously suggested in order to explain the inhibitory 
effect of ethidium on RNA polymerase [ 51. In view 
of the fact that ethidium is only a marginally more 
effective inhibitor of DNA-polymerase than the 
corresponding phenanthridinium derivative which 
lacks the C-6 phenyl substituent, the present results 
are consistent with but do not provide evidence for 
the above mechanism. However it is clear that since 
the conformation of the complex between DNA and 
these two derivatives is similar, the slightly stronger 
inhibitory effect of ethidium may be related to the 
presence of the bulky phenyl substituent, which 
projects into the major groove of DNA [7] and which 
may further impede the ability of the enzyme to 
become attached to or move along the template. 
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